HomeCompareIVIXF vs JEPQ

IVIXF vs JEPQ: Dividend Comparison 2026

IVIXF yields 5420.05% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVIXF wins by $136326195118802.19M in total portfolio value
10 years
IVIXF
IVIXF
● Live price
5420.05%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136326195118802.23M
Annual income
$131,551,666,493,773,860,000.00
Full IVIXF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — IVIXF vs JEPQ

📍 IVIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVIXFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVIXF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVIXF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVIXF
Annual income on $10K today (after 15% tax)
$460,704.61/yr
After 10yr DRIP, annual income (after tax)
$111,818,916,519,707,770,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, IVIXF beats the other by $111,818,916,519,707,770,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVIXF + JEPQ for your $10,000?

IVIXF: 50%JEPQ: 50%
100% JEPQ50/50100% IVIXF
Portfolio after 10yr
$68163097559401.14M
Annual income
$65,775,833,246,886,930,000.00/yr
Blended yield
96.50%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVIXF buys
0
JEPQ buys
0
No recent congressional trades found for IVIXF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVIXFJEPQ
Forward yield5420.05%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$136326195118802.23M$44.8K
Annual income after 10y$131,551,666,493,773,860,000.00$2,152.59
Total dividends collected$136003983287005.17M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IVIXF vs JEPQ ($10,000, DRIP)

YearIVIXF PortfolioIVIXF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$552,705$542,005.42$11,930$1,110.39+$540.8KIVIXF
2$28,588,529$27,997,133.96$14,133$1,224.34+$28.57MIVIXF
3$1,383,995,048$1,353,405,322.61$16,632$1,340.46+$1383.98MIVIXF
4$62,714,057,337$61,233,182,635.19$19,454$1,457.97+$62714.04MIVIXF
5$2,660,288,543,813$2,593,184,502,462.66$22,626$1,576.08+$2660288.52MIVIXF
6$105,651,330,702,723$102,804,821,960,842.73$26,175$1,694.09+$105651330.68MIVIXF
7$3,928,761,972,612,137$3,815,715,048,760,222.50$30,133$1,811.32+$3928761972.58MIVIXF
8$136,812,745,737,264,320$132,608,970,426,569,340.00$34,531$1,927.17+$136812745737.23MIVIXF
9$4,462,176,285,073,260,500$4,315,786,647,134,387,700.00$39,403$2,041.08+$4462176285073.22MIVIXF
10$136,326,195,118,802,240,000$131,551,666,493,773,860,000.00$44,787$2,152.59+$136326195118802.19MIVIXF

IVIXF vs JEPQ: Complete Analysis 2026

IVIXFStock

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full IVIXF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this IVIXF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVIXF vs SCHDIVIXF vs JEPIIVIXF vs OIVIXF vs KOIVIXF vs MAINIVIXF vs XYLDIVIXF vs QYLDIVIXF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.